Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphoma. (16th December 2016)

Record Type:: Journal Article
Title:: Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphoma. (16th December 2016)
Main Title:: Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphoma
Authors:: Kalac, Matko
Lue, Jennifer K.
Lichtenstein, Emily
Turenne, Ithamar
Rojas, Celeste
Amengual, Jennifer E.
Sawas, Ahmed
Deng, Changchun
Mapara, Markus Y.
Connors, Joseph M.
Kuruvilla, John
O'Connor, Owen A.
Abstract:
Is Part Of:: British journal of haematology. Volume 180:Number 5(2018)
Journal:: British journal of haematology
Issue:: Volume 180:Number 5(2018)
Issue Display:: Volume 180, Issue 5 (2018)
Year:: 2018
Volume:: 180
Issue:: 5
Issue Sort Value:: 2018-0180-0005-0000
Page Start:: 757
Page End:: 760
Publication Date:: 2016-12-16
Subjects:: Hodgkin lymphoma -- refractory disease -- monoclonal antibodies -- antibody‐drug conjugate -- autologous stem cell transplant
Hematology -- Periodicals
Blood -- Diseases -- Periodicals
616.15
Journal URLs:: http://www.blacksci.co.uk/%7Ecgilib/jnlpage.bin?Journal=bjh&File=bjh&Page=aims ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2141 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/bjh.14449 ↗
Languages:: English
ISSNs:: 0007-1048
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 2309.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 5898.xml